Center for Human Cell Therapy Boston
OverviewThe Center for Human Cell Therapy (CHCT) is a unique resource that functions across different departments and affiliated institutions of Harvard Medical School (HMS) to facilitate the development of new cellular therapies for human disease. The Center for Human Cell Therapy (CHCT) at the Immune Disease Institute (IDI) was established to provide an infrastructure to rapidly translate novel cell therapy protocols from the laboratory to the clinic. The Center is a cross-institutional effort, drawing its leadership and resources from the following institutions: Children's Hospital Boston (CHB), Dana-Farber Cancer Institute (DFCI), and Massachusetts General Hospital (MGH) as well as the CBRI. Anchored by its Translational Cell Therapy Laboratory (TransLab) and its Regulatory Core, the Center is designed to provide cell therapy resources for the Harvard community and its affiliated hospitals, from the technical level to the submission of Clinical Protocols and Investigational New Drug applications.
Mission
The mandate of the CHCT is to provide resources to all Harvard Medical School faculty to facilitate bench-to-bedside development of cellular therapies for the treatment of damaged or diseased tissues. Examples of such diseases include the correction of congenital defects and various cancers such as childhood and adult leukemia, prostate and ovarian cancers.Participating Institutions Institutions participating in the Center for Human Cell Therapy at the Immune Disease Institute include: Dana-Farber Cancer InstituteChildren's Hospital BostonMassachusetts General HospitalBrigham and Women's HospitalBeth Israel Deaconess Medical Center
Center for Human Cell Therapy
Karp Family Research Building
One Blackfan Circle
Boston, MA, 02115
www.chct.org
copyright 2005 Center for Human Cell Therapy. All rights reserved
